Lam, Grace Y.
Desai, Sameer
Fu, Joey
Hu, Xun Yang
Jang, Jiah
Goshtasebi, Azita
Kalyan, Shirin
Quon, Bradley S.
Funding for this research was provided by:
Gilead Sciences
Michael Smith Foundation for Health Research
Rare Disease Foundation
Article History
Received: 26 February 2021
Accepted: 9 July 2021
First Online: 28 July 2021
Competing interests
: SK is the Vice President of Scientific Innovation at Qu Biologics, a Canadian clinical-stage biotechnology company. All other authors declare no competing interests